Apple said it will stop sales of some of its Apple Watch products later this month due to a patent dispute over the devices' blood oxygen monitor.
The tech giant said it is “taking precautionary measures to comply” in case a ruling by the US International Trade Commission (ITC) on the patent dispute is stayed.
“This includes suspending sales of Apple Watch Series 9 and Apple Watch Ultra 2 on Apple.com starting December 21 and in Apple retail stores after December 24,” Apple said in an email to CBS MoneyWatch.
The legal dispute arises from the blood oxygen characteristic on the devices, which allows Apple Watch users to measure the level of oxygen in their blood. Low blood oxygen levels can lead to serious health problems, according to the Cleveland Clinic.
Apple's decision comes after the ITC ruled that the tech giant had illegally incorporated blood oxygen technology from Masimo, a medical technology company, and ordered Apple to stop importing the devices. A presidential review panel is reviewing the ITC order, and that review period is scheduled to end on December 25. That deadline led Apple to recall the devices starting this week.
“Apple does not agree with the order and is pursuing a number of legal and technical options to ensure that Apple Watch is available to customers,” Apple said in its email.
Thanks for reading CBS NEWS.
Create your free account or log in
for more features.
News USA Today has a skilled online editor and content writer, boasting six years of experience in Media and Broadcasting. News, Finance, Sports, Travel, and Entertainment.